CHINA PHARMA HOLDINGS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$67.32 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-11-14
- 2017-09-30: Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month -$67.32K.
- 2016-09-30: Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month -$86.35K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month |
|---|---|
| 2017-09-30 | -$67.32K 10-Q · filed 2017-11-14 |
| 2016-09-30 | -$86.35K 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |